Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Shunda Du"'
Autor:
Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 4, Pp 735-755 (2024)
Background/Aims Hepatitis B virus (HBV)-DNA integration in HBV-related hepatocellular carcinoma (HBV-HCC) can be targeted by HBV-specific T cells. SCG101 is an autologous, HBV-specific T-cell product expressing a T-cell receptor (TCR) after lentivira
Externí odkaz:
https://doaj.org/article/63b8b049c5274794b59aec58db09d524
Autor:
Kaige Deng, Jiali Xing, Gang Xu, Ruixue Ma, Bao Jin, Zijian Leng, Xueshuai Wan, Jingyong Xu, Xiaolei Shi, Jiangchun Qiao, Jiayin Yang, Jinghai Song, Yongchang Zheng, Xinting Sang, Shunda Du
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Gallbladder cancer (GBC) is a highly aggressive malignancy, with limited survival profiles after curative surgeries. This study aimed to develop a practical model for predicting the postoperative overall survival (OS) in GBC patie
Externí odkaz:
https://doaj.org/article/4558b6aa2c564b88bb23d985b9002596
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Hepatocellular Carcinoma (HCC), the most common primary liver cancer, ranks as the third most common cause of cancer-related deaths globally. A deeper understanding of the cell death mechanisms in HCC is essential for developing more effecti
Externí odkaz:
https://doaj.org/article/0860ac4ad0644e52b98bddccfe68c86d
Autor:
Junwei Zhang, Lei Zhang, Xiaobo Yang, Yongchang Zheng, Haifeng Xu, Shunda Du, Yilei Mao, Xinting Sang, Haitao Zhao, Yiyao Xu, Xin Lu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The influence of liver fibrosis on the rate of liver regeneration and complications following ALPPS has yet to be fully understood. This study aimed to scrutinize the effects of liver fibrosis on the postoperative complications, and prognosi
Externí odkaz:
https://doaj.org/article/d782480f6f8340678ba5a83615337f0a
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Cellular immunotherapy has shown considerable potential for the treatment of primary liver cancer (PLC), particularly hepatocellular carcinoma (HCC), although it is in the early stages of development. This study used bibliometric methods to delineate
Externí odkaz:
https://doaj.org/article/0dcd9b79b86d4dba8b535658a010d8ee
Autor:
Ting Zhang, Shitao Jiang, Lei Zhang, Yaoge Liu, Han Zheng, Haitao Zhao, Shunda Du, Yiyao Xu, Xin Lu
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Oncolytic virotherapy in combination with immunotherapy has demonstrated significant survival benefits in some types of cancer. Here, we summarized the development, research hotpots and potential trends of the combination therapy using visual bibliom
Externí odkaz:
https://doaj.org/article/ae14cb40fecb4a11bd4f034b03d56761
Autor:
Baoluhe Zhang, Bao Jin, Xiang'an Wu, Jiali Xing, Xiao Liu, Xueshuai Wan, Haifeng Xu, Yiyao Xu, Yilei Mao, Qian Chen, Yating Bai, Mei Guan, Shunda Du
Publikováno v:
Cancer Medicine, Vol 13, Iss 16, Pp n/a-n/a (2024)
Abstract Background This study explores molecular features associated with better prognosis in cholangiocarcinoma (CCA). Methods and Results The transcriptomic and whole‐exome sequencing data obtained from paired tissues of 70 were analyzed, groupi
Externí odkaz:
https://doaj.org/article/9a79c1b38a4e44b29c807593cf85dcb1
Autor:
Yihebali Chi, Liming Jiang, Susheng Shi, Shun He, Chunmei Bai, Dan Cao, Jianqiang Cai, Qichen Chen, Xiao Chen, Yiqiao Deng, Shunda Du, Zhen Huang, Li Huo, Yuan Ji, Jie Li, Wenhui Lou, Jie Luo, Xueying Shi, Lijie Song, Bei Sun, Huangying Tan, Feng Wang, Xuan Wang, Zhewen Wei, Wenming Wu, Dianrong Xiu, Jianming Xu, Huadan Xue, Yi Yang, Fei Yin, Jiangyuan Yu, Chunhui Yuan, Yefan Zhang, Weixun Zhou, Dongbing Zhao, Hong Zhao
Publikováno v:
Journal of Pancreatology, Vol 6, Iss 4, Pp 139-150 (2023)
Many management strategies are available for pancreatic neuroendocrine neoplasms with liver metastases. However, a lack of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of these strategi
Externí odkaz:
https://doaj.org/article/927be56a33384c70998585fbd3b94197
Autor:
Xinyu Bi, Yinying Lu, Bo Chen, Zhengqiang Yang, Zhixian Hong, Hanping Wang, Yongkun Sun, Xiaodong Wang, Chunwang Yuan, Daobing Zeng, Zhen Huang, Aiping Zhou, Wen Zhang, Shunda Du, Jianjun Zhao, Jianguo Zhou, Yirui Zhai, Xu Che, Hong Zhao, Haitao Zhao, Jianqiang Cai
Publikováno v:
Liver Cancer, Pp 1-1 (2024)
Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality; it ranks as the second most common cause of cancer deaths in China. Most HCC patients are first diagnosed at an advanced stage. In recent years, targeted therapy combined wi
Externí odkaz:
https://doaj.org/article/2163b2d389d24be98dd939673a4bbcb4
Autor:
Xiangan Wu, Xiaokun Chen, Xiao Liu, Bao Jin, Yuke Zhang, Yuxin Wang, Haifeng Xu, Xueshuai Wan, Yongchang Zheng, Lai Xu, Yi Xiao, Zhengju Chen, Haiwen Wang, Yilei Mao, Xin Lu, Xinting Sang, Lin Zhao, Shunda Du
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e30841- (2024)
Background: Long noncoding RNAs (lncRNAs) have emerged as critical regulators of colorectal cancer (CRC) progression, but their roles and underlying mechanisms in colorectal cancer liver metastases (CRLMs) remain poorly understood. Methods: To explor
Externí odkaz:
https://doaj.org/article/3cd13d08faad45e3a90fb8248ba195e4